In vitro toxicity and efficacy of verdinexor, an exportin 1 inhibitor, on opportunistic viruses affecting immunocompromised individuals

• Douglas G. Widman ,

  Roles Formal analysis, Writing – original draft, Writing – review & editing

  * E-mail: dwidman@karypopharm.com

  Affiliation Karyopharm Therapeutics, Department of Neurofegenerative and Infectious Diseases, Newton, Massachussets, United States of America

  http://orcid.org/0000-0002-3585-6373

  ⨯
• Savanna Gornisiewicz,

  Roles Data curation, Project administration, Writing – original draft, Writing – review & editing

  Affiliation Karyopharm Therapeutics, Department of Neurofegenerative and Infectious Diseases, Newton, Massachussets, United States of America

  ⨯
• Sharon Shacham,

  Roles Funding acquisition, Project administration, Resources, Supervision

  Affiliation Karyopharm Therapeutics, Department of Neurofegenerative and Infectious Diseases, Newton, Massachussets, United States of America

  ⨯
• Sharon Tamir

  Roles Conceptualization, Formal analysis, Funding acquisition, Project administration, Resources, Supervision, Writing – original draft, Writing – review & editing

  Affiliation Karyopharm Therapeutics, Department of Neurofegenerative and Infectious Diseases, Newton, Massachussets, United States of America

  ⨯